Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Non-cash Items (2016 - 2017)

Agios Pharmaceuticals (AGIO) has disclosed Non-cash Items for 5 consecutive years, with $2.9 million as the latest value for Q1 2017.

  • For the quarter ending Q1 2017, Non-cash Items fell 95.99% year-over-year to $2.9 million, compared with a TTM value of $2.9 million through Mar 2017, down 95.99%, and an annual FY2016 reading of $63.6 million, up 2903.87% over the prior year.
  • Non-cash Items was $2.9 million for Q1 2017 at Agios Pharmaceuticals, down from $63.6 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $331.3 million in Q2 2015 and bottomed at $1.7 million in Q1 2015.
  • Average Non-cash Items over 4 years is $74.0 million, with a median of $5.8 million recorded in 2013.
  • Peak annual rise in Non-cash Items hit 4257.25% in 2016, while the deepest fall reached 99.26% in 2016.
  • Year by year, Non-cash Items stood at $5.8 million in 2013, then soared by 2547.81% to $153.6 million in 2015, then tumbled by 58.61% to $63.6 million in 2016, then plummeted by 95.42% to $2.9 million in 2017.
  • Business Quant data shows Non-cash Items for AGIO at $2.9 million in Q1 2017, $63.6 million in Q4 2016, and $2.6 million in Q3 2016.